NETEC Resource Library

Therapeutics for Ebola virus disease

Elemento

Click for External Resource*


Click to read full article*


*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.


Files for Download

9789240055742-eng.pdf9789240055742-eng.pdf

Item Type

Publicación

Terms of Use

By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.

Visor de documentos

Was this resource helpful?


Título

Therapeutics for Ebola virus disease

Descripción

The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD.

Autor

Fecha

2022-08-19

Citación

Therapeutics for Ebola virus disease, 19 August 2022. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.

Resumen

Overview

The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their illness is important. 

The living guidance is available in both pdf format (via the ‘Download’ button) and via anonline platform in both French and English, and is updated regularly as new evidence emerges. 

This first version of the Clinical management for EVD living guidance contains four new recommendations regarding use of therapeutics for EVD, this includes two strong recommendations for the use of monoclonal antibody therapies. This new living guideline is written to accompany the optimized supportive care (oSoC) for EVD standard operating procedures (5, 6). The living guideline aims to summarize high quality evidence for EVD therapeutics and make recommendations for their use.

Accesibilidad

CC BY-NC-SA 3.0 IGO

Collection

Related Resource Topic Exhibits